Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Characteristics in Healthy Adults and Critically Ill Patients
Johannes E. Wehner, Martin Boehne MD, Sascha David MD and 3 more
Clinical and Applied Thrombosis/Hemostasis · 2020
doi:10.1177/1076029620975494 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References15
- 6.
14 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.